EQUITY RESEARCH MEMO

IRadimed (IRMD)

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)70/100

IRadimed Corporation is a specialized medical device company that develops non-magnetic equipment for patient care within MRI environments. Its proprietary portfolio includes the world’s only non-magnetic MRI patient monitors and the MRidium line of MRI-safe IV infusion pump systems, along with ferrous metal detection systems. These products address critical safety and continuity-of-care challenges for high-acuity patients undergoing MRI procedures. With a focused product line and a strong intellectual property position, IRadimed has established itself as the leading provider of MRI-compatible monitoring and infusion solutions, primarily targeting hospital radiology departments and critical care units.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) clearance for next-generation MRI-safe infusion pump80% success
  • Q4 2026Expansion into European market via CE mark approval for infusion pump70% success
  • Q2 2026Q2 2026 earnings release with potential guidance upgrade90% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)